Surprisingly, the AUC value of B2M expression in predicting CL and ME subtypes were 91.4% and 90.7% in pan-gliomas and LGGs, respectively, indicating that B2M effectively predicted the more aggressive subtypes. The gene discussed is B2M; the disease is central nervous system cancer.